Title 21
Title 21 / Section 355b
Search
Search the current U.S. Code within Title 21
Search by citation or keyword across the current edition within Title 21.
20 results
505
Scoped to Title 21
Title 21
Title 21 / Section 875
Title 21
Title 21 / Section 355c–1
Title 21
Title 21 / Section 355d
21 U.S.C. § 355d
Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
Title 21
Title 21 / Section 360a–1
Title 21
Title 21 / Section 360n–1
21 U.S.C. § 360n–1
Priority review for qualified infectious disease products
Priority review for qualified infectious disease products
Title 21
Title 21 / Section 393a
Title 21
Title 21 / Section 825
Title 21
Title 21 / Section 962
Title 21
Title 21 / Section 355e
Title 21
Title 21 / Section 355g
Title 21
Title 21 / Section 301
Title 21
Title 21 / Section 321
Title 21
Title 21 / Section 331
Title 21
Title 21 / Section 355
Title 21
Title 21 / Section 355a
Title 21
Title 21 / Section 355c
21 U.S.C. § 355c
Research into pediatric uses for drugs and biological products
Research into pediatric uses for drugs and biological products
Title 21
Title 21 / Section 355f
21 U.S.C. § 355f
Extension of exclusivity period for new qualified infectious disease products
Extension of exclusivity period for new qualified infectious disease products
Title 21
Title 21 / Section 355h
21 U.S.C. § 355h
Regulation of certain nonprescription drugs that are marketed without an approved drug application
Regulation of certain nonprescription drugs that are marketed without an approved drug application
Title 21
Title 21 / Section 355–1
21 U.S.C. § 355–1
Risk evaluation and mitigation strategies
Risk evaluation and mitigation strategies